WHO ICTRP trial
Efficacy and safety of weekly basal insulin icodec in elderly type 2 diabetes…
JPRN-UMIN000058383 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000058383 |
|---|---|
| Public title | Efficacy and safety of weekly basal insulin icodec in elderly type 2 diabetes patients with insufficient self-management of insulin therapy |
| Scientific title | Efficacy and safety of weekly basal insulin icodec in elderly type 2 diabetes patients with insufficient self-management of insulin therapy - Efficacy and safety of weekly basal insulin icodec in elderly type 2 diabetes patients with insufficient self-management of insulin therapy |
| Primary sponsor | Amami Central Hospital Department of Diabetes Akiko Tsuchiya |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Type 2 Diabetes |
| Interventions | Switching from existing basal insulin therapy to insulin icodec, a weekly subcutaneous basal insulin analogue. |
| Registration date | Jul 7, 2025 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: